|
1
|
Li X, Lu Q, Xie W, Wang Y and Wang G:
Anti-tumor effects of triptolide on angiogenesis and cell apoptosis
in osteosarcoma cells by inducing autophagy via repressing
Wnt/β-Catenin signaling. Biochem Biophys Res Commun. 496:443–449.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lo YC, Lin YC, Huang YF, Hsieh CP, Wu CC,
Chang IL, Chen CL, Cheng CH and Chen HY: Carnosol-induced ROS
inhibits cell viability of human osteosarcoma by apoptosis and
autophagy. Am J Chin Med. 45:1761–1772. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu ZR, Sun LZ, Jia TH and Jia DF:
β-Aescin shows potent antiproliferative activity in osteosarcoma
cells by inducing autophagy, ROS generation and mitochondrial
membrane potential loss. J BUON. 22:1582–1586. 2017.PubMed/NCBI
|
|
4
|
Xu HY, Fang W, Huang ZW, Lu JC, Wang YQ,
Tang QL, Song GH, Kang Y, Zhu XJ, Zou CY, et al: Metformin reduces
SATB2-mediated osteosarcoma stem cell-like phenotype and tumor
growth via inhibition of N-cadherin/NF-kB signaling. Eur Rev Med
Pharmacol Sci. 21:4516–4528. 2017.PubMed/NCBI
|
|
5
|
Shaikh AB, Li F, Li M, He B, He X, Chen G,
Guo B, Li D, Jiang F, Dang L, et al: Present advances and future
perspectives of molecular targeted therapy for osteosarcoma. Int J
Mol Sci. 17:5062016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu L, Ai J, Long H, Liu W, Wang X, Zuo Y,
Li Y, Wu Q and Deng Y: Intergrative microRNA and gene profiling
data analysis reveals novel biomarkers and mechanisms for lung
cancer. Oncotarget. 7:8441–8454. 2016.PubMed/NCBI
|
|
7
|
Tsai MM, Wang CS, Tsai CY, Huang HW, Chi
HC, Lin YH, Lu PH and Lin KH: Potential diagnostic, prognostic and
therapeutic targets of microRNAs in human gastric cancer. Int J Mol
Sci. 17:E9452016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao H, Li M, Li L, Yang X, Lan G and
Zhang Y: MiR-133b is down-regulated in human osteosarcoma and
inhibits osteosarcoma cells proliferation, migration and invasion,
and promotes apoptosis. PLoS One. 8:e835712013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaukoniemi KM, Rauhala HE, Scaravilli M,
Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL and
Visakorpi T: Epigenetically altered miR-193b targets cyclin D1 in
prostate cancer. Cancer Med. 4:1417–1425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zimmerman AL and Wu S: MicroRNAs, cancer
and cancer stem cells. Cancer Lett. 300:10–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schwarzenbacher D, Balic M and Pichler M:
The role of microRNAs in breast cancer stem cells. Int J Mol Sci.
14:14712–14723. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Friedman JM and Jones PA: MicroRNAs:
Critical mediators of differentiation, development and disease.
Swiss Med Wkly. 139:466–472. 2009.PubMed/NCBI
|
|
14
|
Schneider MR: MicroRNAs as novel players
in skin development, homeostasis and disease. Br J Dermatol.
166:22–28. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Coghlin C and Murray GI: Current and
emerging concepts in tumour metastasis. J Pathol. 222:1–15. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Kim J, Mueller AC, Dey B, Yang Y,
Lee DH, Hachmann J, Finderle S, Park DM, Christensen J, et al:
Multiple receptor tyrosine kinases converge on microRNA-134 to
control KRAS, STAT5B, and glioblastoma. Cell Death Differ.
21:720–734. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garg M: Emerging role of microRNAs in
cancer stem cells: Implications in cancer therapy. World J Stem
Cells. 7:1078–1089. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bicker S and Schratt G: microRNAs: Tiny
regulators of synapse function in development and disease. J Cell
Mol Med. 12:1466–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Condorelli G and Dimmeler S: MicroRNAs:
Components of an integrated system controlling cardiac development,
physiology, and disease pathogenesis. Cardiovasc Res. 79:551–552.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He X, Eberhart JK and Postlethwait JH:
MicroRNAs and micromanaging the skeleton in disease, development
and evolution. J Cell Mol Med. 13:606–618. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chhabra R and Saini N: MicroRNAs in cancer
stem cells: Current status and future directions. Tumour Biol.
35:8395–8405. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu M, Lu S, He W, Zhang L, Ma Y, Lv P, Ma
M, Yu W, Wang J, Zhang M, et al: ULK1-regulated autophagy: A
mechanism in cellular protection for ALDH2 against hyperglycemia.
Toxicol Lett. 283:106–115. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ji Q, Karnak D, Hao P, Wang R and Xu L: No
small matter: MicroRNAs - key regulators of cancer stem cells. Int
J Clin Exp Med. 3:84–87. 2010.PubMed/NCBI
|
|
25
|
Nimmo RA and Slack FJ: An elegant miRror:
MicroRNAs in stem cells, developmental timing and cancer.
Chromosoma. 118:405–418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meng F, Glaser SS, Francis H, DeMorrow S,
Han Y, Passarini JD, Stokes A, Cleary JP, Liu X, Venter J, et al:
Functional analysis of microRNAs in human hepatocellular cancer
stem cells. J Cell Mol Med. 16:160–173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia H and Hui KM: MicroRNAs involved in
regulating epithelial-mesenchymal transition and cancer stem cells
as molecular targets for cancer therapeutics. Cancer Gene Ther.
19:723–730. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen Y, Pan Y, Xu L, Chen L, Liu L, Chen
H, Chen Z and Meng Z: Identifying microRNA-mRNA regulatory network
in gemcitabine-resistant cells derived from human pancreatic cancer
cells. Tumour Biol. 36:4525–4534. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang YH, Yang YL, Huang FC, Tiao MM, Lin
YC, Tsai MH and Wang FS: MicroRNA-29a mitigation of endoplasmic
reticulum and autophagy aberrance counteracts in obstructive
jaundice-induced fibrosis in mice. Exp Boil Med (Maywood).
243:13–21. 2018. View Article : Google Scholar
|
|
30
|
Tian J, An X and Niu L: Role of microRNAs
in cardiac development and disease. Exp Ther Med. 13:3–8. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsuchiya H, Tomita K, Mori Y, Asada N,
Morinaga T, Kitano S and Yamamoto N: Caffeine-assisted chemotherapy
and minimized tumor excision for nonmetastatic osteosarcoma.
Anticancer Res. 18:657–666. 1998.PubMed/NCBI
|
|
34
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Magri F, Vanoli F and Corti S: miRNA in
spinal muscular atrophy pathogenesis and therapy. J Cell Mol Med.
22:755–767. 2018.PubMed/NCBI
|
|
36
|
Romakina VV, Zhirov IV, Nasonova SN,
Zaseeva AV, Kochetov AG, Liang OV and Tereshchenko SN: MicroRNAs as
biomarkers of cardiovascular diseases. Kardiologiia. 66–71.
2018.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tian K, Wang L, Di R, Xu J, Li G and Li Z:
Effect and mechanism of miRNA to osteosarcoma cell. Pak J Pharm
Sci. 27 (5 Suppl):1657–1660. 2014.PubMed/NCBI
|
|
38
|
Xie B, Li Y, Zhao R, Xu Y, Wu Y, Wang J,
Xia D, Han W and Chen D: Identification of key genes and miRNAs in
osteosarcoma patients with chemoresistance by bioinformatics
analysis. Biomed Res Int. 2018:47610642018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu X, Liu T, Fang O, Dong W, Zhang F,
Leach L, Hu X and Luo Z: MicroRNA-708-5p acts as a therapeutic
agent against metastatic lung cancer. Oncotarget. 7:2417–2432.
2016.PubMed/NCBI
|
|
40
|
Yang J, Wei J, Wu Y, Wang Z, Guo Y, Lee P
and Li X: Metformin induces ER stress-dependent apoptosis through
miR-708-5p/NNAT pathway in prostate cancer. Oncogenesis.
4:e1582015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dodurga Y, Seçme M and Lale
Şatıroğlu-Tufan N: A novel oncogene URG4/URGCP and its role in
cancer. Gene. 668:12–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu G, Zhang T, Jing Y, Bao Q, Tang Q and
Zhang Y: miR-519 suppresses nasopharyngeal carcinoma cell
proliferation by targeting oncogene URG4/URGCP. Life Sci.
175:47–51. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tokay E and Kockar F: Identification of
intracellular pathways through which TGF-β1 upregulates URG-4/URGCP
gene expression in hepatoma cells. Life Sci. 144:121–128. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dodurga Y, Seçme M, Eroğlu C, Gündoğdu G,
Avcı ÇB, Bağcı G, Küçükatay V and Lale Şatıroğlu-Tufan N:
Investigation of the effects of a sulfite molecule on human
neuroblastoma cells via a novel oncogene URG4/URGCP. Life Sci.
143:27–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cai J, Li R, Xu X, Zhang L, Wu S, Yang T,
Fang L, Wu J, Zhu X, Li M and Huang Y: URGCP promotes non-small
cell lung cancer invasiveness by activating the NF-κB-MMP-9
pathway. Oncotarget. 6:36489–36504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu M, Chen J, Wang Y, Hu J, Liu C, Feng C
and Zeng X: URGCP/URG4 promotes apoptotic resistance in bladder
cancer cells by activating NF-κB signaling. Oncotarget.
6:30887–30901. 2015.PubMed/NCBI
|
|
47
|
Xing S, Zhang B, Hua R, Tai WC, Zeng Z,
Xie B, Huang C, Xue J, Xiong S, Yang J, et al: URG4/URGCP enhances
the angiogenic capacity of human hepatocellular carcinoma cells in
vitro via activation of the NF-κB signaling pathway. BMC Cancer.
15:3682015. View Article : Google Scholar : PubMed/NCBI
|
